ESPAUR 2021/22 Webinar

The United Kingdom Health Security Agency (UKHSA) held a webinar summarising the key findings from the English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2021 to 2022.  

The recording from the webinar that took place on Wednesday 23 November is available below.  

Agenda 

Chair: Dr Diane Ashiru-Oredope 

Data presented is from 1 April 2021 to 31 March 2022 unless otherwise specified. Methods are not presented, for full details please refer to the ESPAUR Report. 

Recording  

ESPAUR Report Webinar Part 1 

ESPAUR Report Webinar Part 2 

Feedback  

Thank you for watching, we would be very grateful for your feedback. Please complete the webinar feedback questionnaire below:  

• ESPAUR Report Webinar feedback form 

Acknowledgements 

An asterix (*) denotes the chapter leads.  

Chapter 1. Introduction  

Neil Cunningham, Susan Hopkins. 

Chapter 2. Antimicrobial resistance  

Rebecca Guy*, Hannah Higgins, Jamie Rudman, Holly Fountain, Katherine Henderson*, Kirsty Bennet, Katie Hopkins, Alicia Demirjian, Sarah Gerver*, Mariyam Mirfenderesky*. 

Chapter 3. Antimicrobial consumption  

Sabine Bou-Antoun*, Angela Falola, Holly Fountain, Hanna Squire, Colin Brown, Susan Hopkins, Sarah Gerver, Alicia Demirjian*. 

Chapter 4. Antimicrobial stewardship  

Ella Casale*, Catherine Hayes*, Donna Lecky, Luke O’Neil, Eirwen Sides, Emily Cooper, Fionna Pursey, Sejal Parekh, Louis Fisher, Brian MacKenna Eleanor Harvey, Diane AshiruOredope*. 

Chapter 5. NHS England: improvement and assurance schemes 

Kieran Hand*, Elizabeth Beech, Monsey McLeod, Sabine Bou-Antoun, Hanna Squire, Emma Budd, Jeff Featherstone, Sejal Parekh, Donna Lecky, Catherine Hayes, Diane Ashiru-Oredope, Preety Ramdut, Conor Jamieson, Gill Damant, Naomi Fleming, Philip Howard, Laura Whitney.  

Chapter 6. Professional education and training and public engagement 

Catherine Hayes*, Jordan Charlesworth, Diane Ashiru-Oredope, Eirwen Sides, Amy Jackson, Emily Cooper, Brieze Read, Donna Seaton, Lorna Flintham, Harpreet Sidhu, Donna Lecky*. 

Chapter 7. COVID-19 therapeutics  

Hanna Squire*, Alessandra Lochen*, Diane Ashiru-Oredope, Kieran Hand, Hassan Hartman, Carry Triggs-Hodge, Holly Fountain, Sabine Bou-Antoun, Sarah Gerver*, Alicia Demirjian*. 

Chapter 8. Research  

Emily Agnew*, Jordan Charlesworth, Joanna Bacon, Esmita Charani, Jane Turton, Rebecca Guy, Samuel Lipworth, Aleksandra Borek, Simon Collin, Diane Ashiru-Oredope, Gisela Robles Aguilar, Nichola Naylor, Alice Ledda, Ross Booton, Amelia Andrews, Mark Sutton, Ginny Moore, Nicole Stoesser, Donna Lecky, Hannah Higgins, Caroline Jamieson-Leadbitter, Sarah Tonkin-Crine, Alison Holmes, Sarah A Walker, Julie Robotham*. 

Chapter 9. Stakeholder engagement  

Carry Triggs-Hodge*, Gil Damant, Tamsin Dewe, Jeff Featherstone, Kitty Healey, Martin Astbury, Natasha Bell-Asher, Nicholas Brown, Mary Collier, Judith Ewing, Naomi Fleming, Rose Gallagher, Kieran Hand, Martin Llewelyn, William Malcolm, Sannah Malik, Arianne Matlin, Nicholas Reid, Tracy Rogers, Wendy Thompson, Jonathan Underhill, Fiona Watson, Lydia Gomersall, Simon Hartnett-Welch, Diane Ashiru-Oredope*.  

Further acknowledgements  

With very many thanks to the ESPAUR Oversight Group for their help in reviewing this report.  

The authors would also like to extend sincere thanks to Jon White for creating the infographics and Simon Port for formatting and proof-reading the report and related documents. 

The authors would like to express their utmost thanks to Professor Alan Johnson, who although retired in March 2019 has helped edit this report and all the previous ESPAUR reports. 

This report has been led by Diane Ashiru-Oredope and project managed by Ella Casale, with huge thanks to the support of the ESPAUR Oversight Group Secretariat, Carry Triggs-Hodge.